Cell therapy for recent spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests whether a new cell therapy (XS228) can help people with recent spinal cord injuries recover function. The cells are given through a spinal tap and are designed to replace damaged nerve cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You had a spinal cord injury 14 to 60 days ago, from your neck (C4) to your lower back (L2).
- Your injury is classified as AIS A, B, or C (complete or incomplete but not mild).
- You do not have serious other injuries or health problems that could affect the study results.
- You agree to use effective non-hormonal birth control during the trial and for 6 months after.
- You or your legal guardian can understand and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
This study tests a new treatment for spinal cord injury that is given through a spinal tap. It is for people with a recent or past spinal cord injury who are at least 18 years old. The treatment may help improve recovery.
This trial tests a combination of stem cells injected into the spinal fluid and a non-invasive spinal cord stimulation device to see if they can improve recovery after a spinal cord injury. It is for people who have had a single traumatic injury between neck and mid-back, 1 to 5 years ago, and are in stable health.
This trial tests whether transplanting cells from your nose, combined with intensive exercise therapy, can help repair long-term spinal cord injuries. You'll receive a surgical procedure and then participate in structured rehabilitation five days a week for several months.
This trial tests a device that delivers a special cell therapy (LCTOPC1) into the spinal cord. It is for people with a recent or chronic spinal cord injury that is severe (no feeling or movement below the injury) or leaves some sensation but no movement.
This study tests whether a device placed near the spinal cord in your neck (called an epidural stimulator) can help improve arm and hand function after a spinal cord injury. It's designed for people with a long-term, motor-complete injury between the C4 and C7 levels.
Hear when a new Induced Pluripotent Stem Cells trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.